Impact of the cyclooxygenase system on doxorubicin-induced functional MDR1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

Ulrike Puhlmann; Christina Ziemann; Gudrun Ruedell; Hagen Vorwerk; Dirk Schaefer; Claudia Langebrake; Peter Schuermann; Ursula Creutzig; Dirk Reinhardt

doi:10.1124/jpet.104.071571

OtherChemotherapy, Antibiotics, and Gene Therapy

Impact of the cyclooxygenase system on doxorubicin-induced functional MDR1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

Ulrike Puhlmann, Christina Ziemann, Gudrun Ruedell, Hagen Vorwerk, Dirk Schaefer, Claudia Langebrake, Peter Schuermann, Ursula Creutzig and Dirk Reinhardt

Journal of Pharmacology and Experimental Therapeutics October 22, 2004, DOI: https://doi.org/10.1124/jpet.104.071571

Ulrike Puhlmann

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christina Ziemann

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gudrun Ruedell

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hagen Vorwerk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dirk Schaefer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claudia Langebrake

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Schuermann

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ursula Creutzig

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dirk Reinhardt

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 363, Issue 2

1 Nov 2017

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Impact of the cyclooxygenase system on doxorubicin-induced functional MDR1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

Citation Tools

OtherChemotherapy, Antibiotics, and Gene Therapy

Impact of the cyclooxygenase system on doxorubicin-induced functional MDR1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

Ulrike Puhlmann, Christina Ziemann, Gudrun Ruedell, Hagen Vorwerk, Dirk Schaefer, Claudia Langebrake, Peter Schuermann, Ursula Creutzig and Dirk Reinhardt

Journal of Pharmacology and Experimental Therapeutics October 22, 2004, DOI: https://doi.org/10.1124/jpet.104.071571

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherChemotherapy, Antibiotics, and Gene Therapy

Impact of the cyclooxygenase system on doxorubicin-induced functional MDR1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

Ulrike Puhlmann, Christina Ziemann, Gudrun Ruedell, Hagen Vorwerk, Dirk Schaefer, Claudia Langebrake, Peter Schuermann, Ursula Creutzig and Dirk Reinhardt

Journal of Pharmacology and Experimental Therapeutics October 22, 2004, DOI: https://doi.org/10.1124/jpet.104.071571

Permalink: